好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

CMT caused by a mutation in Dystrophin-related protein 2: Exome sequencing reveals a new clinical paradigm
Neuromuscular and Clinical Neurophysiology (EMG)
(-)
008
Authors/Disclosures
Kathryn Brennan, MD
PRESENTER
No disclosure on file
Yunhong Bai (Department of Neurology, University of Iowa) No disclosure on file
Shawna Feely (University of Iowa Hospitals & Clinics) Shawna Feely has nothing to disclose.
Chiara Pisciotta No disclosure on file
William Baskett No disclosure on file
Laurie Gutmann, MD, FAAN The institution of Dr. Gutmann has received research support from NIH. The institution of Dr. Gutmann has received research support from Harmony . Dr. Gutmann has received publishing royalties from a publication relating to health care.
No disclosure on file
No disclosure on file
Stephan Zuchner, MD, FAAN (University of Miami School of Medicine) Dr. Zuchner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Zuchner has received research support from Muscular Dystrophy Association. The institution of Dr. Zuchner has received research support from CMT Association. Dr. Zuchner has received intellectual property interests from a discovery or technology relating to health care.
No disclosure on file
Michael E. Shy, MD, FAAN (University of Iowa) Dr. Shy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Shy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DTx Pharma. The institution of Dr. Shy has received research support from NIH. The institution of Dr. Shy has received research support from Muscular Dystrophy Association. The institution of Dr. Shy has received research support from Charcot Marie Tooth Association. The institution of Dr. Shy has received research support from Applied Therapeutics.